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The real question is not whether machines think but whether men do.
BF Skinner (1904–1990)
Few problems in intensive care demand finer judgment,
further experience, and greater skill than the assessment of
patient physiological variables and this is especially true in
case of cardiopulmonary instability [1]. Therefore, during
the last two decades many intensivists have come to regard
shocks as carrying a high enough mortality risk to deserve
an advanced hemodynamic monitoring. Indeed, new
monitoring techniques in intensive care may improve the
prognosis for shock, so that full advantage can be taken of
these new skills [2]. However, in spite of increased avail-
ability of the monitoring process and monitoring equip-
ment, hemodynamic monitoring has not significantly
improved survival rate.
As part of the present special issue of the Journal of
Clinical Monitoring and Computing, appreciated opinion
leaders provide an outline of the important technologic
advance in hemodynamic monitoring to manage critically ill
patients. The present reviews take a deeper look at physiol-
ogy principles, main beliefs which are the basis of intensive
care medicine [1]. In fact, the assessment of physiological
principles (by these various techniques described in these
reviews) at the bedside, reinforces our use of these principles
in clinical decision making [3]. As example, previous works
have pointed out that classical thermodilution technique,
transpulmonary thermodilution, and pulse-plethysmogra-
phy, are valuable tools in evaluating the hemodynamic status
of critically ill patients [4–6]. On the other hand, when
occurrences not in accord with these principles are observed
and unintelligible observations are documented [7], a new
conception is gained concerning human pathophysiology [7,
8]. In this specific case, such new scheme should improve our
care and the outcome for ICU patients.
For many years it was commonly taught that we should
insist on adequate evaluation of hemodynamic monitoring
before it is implemented. In this regard, over the last decades,
anesthetists and intensivists had the support and resources to
determine the meaning of hemodynamic monitoring using
rigorous scientific methods (Fig. 1). However, it seems quite
dangerous to make robust clinical recommendations in the
absence of proofs on the usefulness of these techniques
regarding patient outcome [9]. Similarly, it could be perti-
nent to ask whether it would not be easier to forgo the
advantages resulting from such a technologic advance as
hemodynamic monitoring. However, sometimes, our
knowledge of these devices and techniques, we use, is
imperfect and our understanding should be improved [10].
Of course, the most significant advantage of hemody-
namic monitoring is that patients will have a more rapid
and complete circulatory state recovery and we should
define what we need to measure and monitor to do that.
This should be done before the technology is too widely
available; a detail that underlines the magnitude of patho-
physiological studies. As well, it must be established and
accepted that specific hemodynamic monitoring is essential
if an appropriate form of intervention or treatment could be
administered with safety. And, in the situation where these
techniques could have the potential to improve patient
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outcome, it would be unethical to forgo its use. I do not
underestimate the difficulty of providing this information
for critically ill patients (in comparison with the peri-
operative setting [11, 12]) at a time when several recent
clinical investigations failed to demonstrate that hemody-
namic monitoring improve survival rate [9, 13]. However,
there is considerable confusion and numerous misconcep-
tions which arise from the particularity of ICU patients and
the point in time when a hemodynamic monitoring is
needed [14].
Finally, another challenge is expense and the formidable
financial charge for intensive care services. Indeed, the cost
of these hemodynamic monitoring techniques is constantly
increasing and such devices consumables are generally not
reusable. What is the solution to this dilemma? Every
technologic development of a device is based on the central
fundamental value of the technique used [15]. On the other
hand, a huge development (bubble) may represent an
increase or rise over that fundamental value. In this regard,
there are many theories regarding the formation of eco-
nomic bubbles and one of them maintains that bubbles are
related to the communication of economic players. By
analogy, in our complex modern society, with its increas-
ing emphasis on the fact that everyone deserves quality
health care, the role of hemodynamic expert as both a
health advocate and a modifier of care processes is fun-
damental. Indeed, health has no price but it has a cost!
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